Evidence map›Paper›PMID 42774040›Full record

ArticleFrontiers in oncology2026

DA-MoE: descriptor-attention mixture-of-experts for multi-class gastrointestinal disease classification.

Yiliu Xu, Lingling Liu, Meiwen Tang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yiliu Xu *Guangxi University of Chinese Medicine, Nanning, China.
Lingling Liu *Hubei University of Chinese Medicine, Wuhan, China.
Meiwen TangGuangxi University of Chinese Medicine, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computer-aided diagnosis (CADx) for gastrointestinal (GI) endoscopy increasingly depends on deep models trained end-to-end on raw images. However, raw images are often unavailable in legacy clinical systems or privacy-sensitive settings. This work presents a methodological study on multi-class GI disease classification from pre-extracted handcrafted descriptors on the public Kvasir benchmark, rather than a clinically validated deployment system. We propose a Descriptor-Attention Mixture-of-Experts (DA-MoE) model tailored to this descriptor-only scenario. DA-MoE first projects heterogeneous descriptors (JCD, Tamura, ColorLayout, EdgeHistogram, AutoColorCorrelogram, and PHOG) into a shared token space and applies transformer-style self-attention for descriptor-level fusion. A descriptor-aware mixture-of-experts classifier then performs sample-adaptive expert routing on the fused representation. Under a unified evaluation protocol using accuracy (ACC), macro F1, and Matthews correlation coefficient (MCC), with five-fold stratified cross-validation and repeated random splits for robustness assessment, DA-MoE achieves 77.4% accuracy and an MCC of 0.75 on the held-out test split, outperforming strong feature-based baselines including a residual multi-layer perceptron (Res-MLP). Ablation studies, hyperparameter analysis, MoE routing interpretability, full per-class metrics, and clustering analysis further show that DA-MoE produces more compact and better-separated representations in descriptor embedding space. These findings support DA-MoE as a practical component of feature-based GI CADx pipelines under data-sharing constraints, but prospective validation on raw endoscopic data remains necessary.

Indexed as

attention mechanismcomputer-aided diagnosisendoscopygastrointestinal disease classificationhandcrafted descriptorsKvasir datasetmixture-of-experts

Identifiers

PMID42774040
PMCPMC13593463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.